Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PCVX | Vaxcyte, Inc. | CHIEF EXECUTIVE OFFICER, Director | $20.8M | -$3.45M | -14.3% | Sep 8, 2025 |
ATHA | Athira Pharma, Inc. | Director | May 30, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|